Children 12–15 are now eligible to receive Pfizer's COVID-19 vaccine, after the U.S. Food and Drug Administration granted emergency use approval. And there is other COVID-19 news.

"This is the first week we have not had an increase in COVID-19 cases in any U.S. state, and in 33 of those states, there was a decrease last week," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "This has not happened on any consistent basis for every U.S. state since the start of this pandemic."

In this Mayo Clinic Q&A podcast, Dr. Poland explains the real world effectiveness of the COVID-19 vaccines, talks about the approval process for these vaccines and answers a number of listener questions.
_________________________________________________

For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.

FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. [ Ссылка ]

FOR THE MEDIA ONLY: Register at [ Ссылка ]... to access clean and nat sound versions of this video on the Mayo Clinic News Network. [ Ссылка ]

Mayo Clinic [ Ссылка ] Follow Mayo Clinic on Instagram:
[ Ссылка ] Like Mayo Clinic on Facebook: [ Ссылка ] Follow Mayo Clinic on Twitter: [ Ссылка ]

Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Janssen Pharmaceuticals Inc., Kentucky BioProcessing Inc. and Genevant Sciences Corp. Honoraria: Elsevier.

свернуть